In this episode, we explore the evolving landscape of B2B digital commerce, focusing on its critical role in contemporary business strategies. Host Gavin McGrath is joined by Corey Highfield from L.E.K. Consulting and Jared Abelson from Simpson Strong-Tie to discuss the importance of digital strategies, the common barriers to adoption, and the steps for successful implementation. Our speakers also explore the nuances of maintaining brand integrity, the significance of data management, and the essentials of internal and external communication in B2B digital commerce.Key Points/Topics Covered:The increasing importance of digital strategies for B2B commerce, driven by a shift in buyer behaviours.Common barriers to effective digital strategy adoption, including pricing integrity and digital immaturity.Importance of data management and foundational infrastructure for successful digital initiatives.The role of clear internal and external communication in rolling out B2B digital commerce strategies.Strategies for managing reseller programs and maintaining consistent product information across channels.Connect with our experts on LinkedIn:Gavin McGrath - L.E.K. Consulting, LLC https://www.linkedin.com/in/gavinmcgrath/Corey Highfield - L.E.K. Consulting, LLC https://www.linkedin.com/in/corey-highfield/Jared Abelson - Simpson Strong-Tie https://www.linkedin.com/in/jabelson/
Visit L.E.K. Consulting at https://www.lek.com/
--------
27:50
A New Generation of Drug Therapies Requires New Business Strategies
Today we look at how advanced therapeutic modalities (ATMs) are revolutionizing drug discovery, development and manufacturing, presenting both unparalleled opportunities and new challenges for businesses.Drawing from their knowledge, our experts Alex Vadas, Adam Siebert and Jeff Holder unpack how new drug therapies such as engineered cell therapies, gene therapies and nucleic acid therapies are revolutionizing patient care and treatment options. They highlight the need for innovative business strategies to navigate complex manufacturing processes and supply chain logistics, the role of regulatory engagement, and the influence of artificial intelligence (AI) and machine learning in the realm of drug discovery.Key points/topics covered:The transformative impact of new drug therapies on life sciences, requiring adaptations in business strategiesThe complexity of manufacturing for ATMs and its effect on the commercial viability of new treatmentsThe importance of regulatory engagement in streamlining the drug development timeline for advanced therapiesThe intersection of AI and machine learning in expediting drug discovery for cell and gene therapiesManufacturing efficiency and supply chain consistency as a key differentiator in the outcomes and success rates of ATMsInterested in learning more? Read our Harvard Business Review article, A New Generation of Drug Therapies Requires New Business Strategies.Connect with our experts on LinkedIn:Alex Vadas, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/alexvadas/Adam Siebert, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/adam-siebert-8772b327/Jeff Holder, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/jeff-holder-ph-d-7a391087/
Visit L.E.K. Consulting at https://www.lek.com/
--------
28:33
Investment Trends and Strategic Priorities in the Specialty Chemicals and Materials Industry
In today’s episode, we will focus on the influential trends and investment priorities shaping the specialty chemicals industry. Our subject matter experts will discuss the surge in innovation, digital transformation, and sustainability in the chemicals sector and highlight the strategic responses to recent industry challenges.Key points/topics covered:Current investment trends and strategic priorities, such as innovation in alternative feedstocks and diversification in the specialty chemicals industryThe implementation and impact of digital strategies, including operational efficiency and business growth, within chemical companiesThe significance of sustainability goals and consumer demand for sustainable products, which are driving specialty chemical manufacturers to innovateActions taken by the chemical industry to promote more sustainable raw materials and leverage biosimilar opportunities and recyclingFuture directions for the chemicals industry, including addressing supply chain optimization and operational efficiencyTo provide insights on these topics, you will hear from L.E.K. Consulting Managing Directors Carol Wingard, Peter Walter, Morgan Callahan and Amanda Davis Winters.Interested in learning more? Read our Article, Key Issue Insights Into the Future of Specialty Chemicals.Connect with our experts on LinkedIn:Carol Wingard: https://www.linkedin.com/in/carolwingardlek/Peter Walter: https://www.linkedin.com/in/peterwalterlek/Morgan Callahan: https://www.linkedin.com/in/morganjcallahan/Amanda Davis Winters: https://www.linkedin.com/in/adaviswinters/
Visit L.E.K. Consulting at https://www.lek.com/
--------
11:13
Scope 3 Emissions: A Strategic Imperative for Pharma Companies
In this episode of “Insight Exchange,” we explore the crucial role of Scope 3 emissions reduction in the pharmaceutical industry. Listen to L.E.K. Consulting experts Verena Ahnert and Max Cambras, who share their insights on the significance of Scope 3 emissions, the current state of commitments in pharma and how emissions reduction is both a strategic consideration and mutually beneficial to both pharma and the environment.Key points/topics covered:Explanation of Scope 3 emissions and their importance in pharmaThe current state of Scope 3 commitments in the pharmaceutical industryKey drivers of Scope 3 emissions in pharmaThe strategic co-benefits of Scope 3 emissions reduction in the pharmaceutical industryThe path to achieving strategic co-benefits through emissions reduction in pharmaTune in for a deep dive into a pressing environmental issue that’s reshaping the pharma industry’s strategies and operations.Interested in learning more? Read our Special Report, Scope 3 Emissions: A Strategic Imperative for Pharma Companies.Connect with our experts on LinkedIn:Verena Ahnert, Partner, L.E.K. Consulting: https://www.linkedin.com/in/verena-ahnert-7a449a2/Max Cambras, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/max-cambras-08348411/
Visit L.E.K. Consulting at https://www.lek.com/
--------
19:08
Navigating US Packaging Trends: The Current Opportunities for Brand Owners
In this discussion, we dive into the world of brand packaging, examining the responses from a thorough survey amongst over 400 brand managers. The episode is led by the expertise of L.E.K. Consulting managing directors Thilo Henkes, Jon Moss and Jeff Cloetingh, as well as Roger Zellner, who analyze the balancing act between innovative packaging solutions and the unfolding pressures of inflation. The conversation explores the far-reaching implications of protective packaging innovation, the pivot towards sustainability in the industry, the necessity of SKU rationalisation, and the nuanced impact of packaging on consumer experiences.Key Points/Topics Covered:The evolving panorama of protective packaging innovation and digital tools enhancing brand experience and supply chain efficiency.The delicate dance brand owners face in managing packaging, ingredients, freight, and transport costs during periods of significant inflation.The drive towards sustainability in packaging, with brand owners hastening investment to meet consumer expectations and industry benchmarks.The strategic considerations behind SKU rationalisation efforts, aimed at streamlining the supply chain and boosting profitability, yet still fostering packaging innovation.Interested in learning more? Read our Article, Brand Owner Sentiment Points to Attractive Opportunities for Packaging.Connect with our experts on LinkedIn:Thilo Henkes, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/thilohenkes/ Jon Moss, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/jon-moss-a71896158/ Jeff Cloetingh, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/jeffcloetingh/ Roger Zellner, Former Director of R&D Packaging, Mondelez International (Current Advisory Board Garlock Flexibles & Industry Consultant): https://www.linkedin.com/in/rogerzellner/
Visit L.E.K. Consulting at https://www.lek.com/
Join us as we swap ideas with thinkers, innovators and doers from around the world and around L.E.K.
Presented by consulting powerhouse L.E.K. Consulting (www.lek.com), Insight Exchange™ is a new forum dedicated to the free and open exchange of the most interesting, important, and urgent ideas in the world of business. From the farthest-reaching environmental issues to innovations in retail, industrials, and healthcare, every installment of Insight Exchange™ invites luminaries to tell us what they’re working on, what they’re worried about, what they’re excited about, and what’s coming next.
Join us on an intrepid journey of discovery as we take nothing for granted, pull no punches, and follow the research no matter where it leads. In its 30+ year history, this is what L.E.K. has done better than anyone in the world. And that’s why Insight Exchange™ is the podcast only L.E.K. could have produced. If you’re a growth investor, an advanced student, an employee, a researcher, an executive, an entrepreneur, an inventor, or a board member, we invite you to join us for Insight Exchange™. If you’d just like to keep your finger on the pulse of what’s happening in business, retail, education, healthcare, industrials, energy, media, or life sciences, we invite you to join us for Insight Exchange™.
France